Cite
MLA Citation
Rimas Lukas et al.. “CTIM-12. A PHASE 1 TRIAL OF IMMUNORADIOTHERAPY WITH THE IDO ENZYME INHIBITOR (BMS-986205) AND NIVOLUMAB IN PATIENTS WITH NEWLY DIAGNOSED MGMT PROMOTER UNMETHYLATED IDHwt GLIOBLASTOMA.” Neuro-oncology, vol. 23, 2021, pp. vi51–vi52. http://access.bl.uk/ark:/81055/vdc_100146090265.0x00002c